Saturday, March 20, 2021
8 a.m.–1:30 p.m. CDT
Organizers:
Axel Grothey, MD– West Cancer Center & Research Institute
Lee S. Schwartzberg, MD, FACP– West Cancer Center & Research Institute
ACI Memphis Program Registration
Registration is for the program is NOW OPEN.
You must be registered to attend the program.
Program Agenda
March 20, Program
The program is hosted through Zoom Webinar.
| 7:45–8 a.m. |
Welcome, Introduction, SITC Resources |
| Session I: Cancer Immunotherapy | |
| 8–8:30 a.m. | Immunotherapy for the Treatment of Skin Cancers David C. Portnoy, MD – West Cancer Center & Research Institute |
| 8:30–9 a.m. | Immunotherapy for the Treatment of Lung Cancer Jason Porter, MD – West Cancer Center & Research Institute |
| 9–9:30 a.m. | Immunotherapy for the Treatment of Hematologic Malignancies Jason C. Chandler, MD – West Cancer Center & Research Institute |
| 9:30–10 a.m. | Immunotherapy for the Treatment of Genitourinary Malignancies |
| 10–10:15 a.m. | Break |
| 10:15–10:45 a.m. | Immunotherapy for the Treatment of Breast Cancer Lee S. Schwartzberg, MD, FACP – West Cancer Center & Research Institute |
| 10:45–11:15 a.m. | Immunotherapy for the Treatment of Additional Solid Tumors Axel Grothey, MD– West Cancer Center & Research Institute |
| Session II: Immunotherapy Challenges and Beyond | |
| 11:15–11:40 a.m. | Practical Barriers in Cancer Immunotherapy Treatment |
| 11:40–11:55 a.m. | Break |
| 11:55 a.m.–12:40 p.m. | Toxicity Management Heather Greene MSN, FNP, AOCNP – West Cancer Center & Research Institute |
| 12:40–1:05 p.m. | What’s Next for Cancer Immunotherapy |
| 1:05–1:25 p.m. | COVID-19 in Cancer Immunotherapy |
| 1:25–1:30 p.m. |
Closing Remarks |
Program Purpose
Specifically designed by the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, nurse practitioners, pharmacists, emergency physicians and the entire cancer care team, the Advances in Cancer Immunotherapy™ (ACI) programs are introductory educational programs. Presented by leading and local authorities in tumor immunology and cancer immunotherapy, these programs will facilitate understanding of:
- The rationale for common approaches to immunotherapy
- The appropriate clinical management of common side effects of immunotherapy agents
- Implementing appropriate cancer immunotherapy treatments for skin, lung, genitourinary, head and neck, hematologic and/or additional solid tumor cancers in clinical practice
- Overcoming operational and financial barriers to integrating cancer immunotherapy into their practice setting
- Appropriate implementation of cancer care counsel in the clinical setting
Attendees will also have an opportunity for connecting with regional experts in the immunotherapy field at the live event, through four quarterly webinars, and indefinitely through a dedicated online community forum. These connections will serve as ongoing resources while clinical oncologists and other healthcare providers incorporate immunotherapy into practice.
Recently, the SITC office received communication about a fraudulent registration website for one of our ACI programs. To help ensure others don’t mistakenly register on an unauthorized, third-party website, we’re proactively informing you to ensure you’re able to safely register for the event through the official SITC website, and so that you can confirm the communication you receive is truly from SITC.
All official forthcoming ACI registration information will come from an email address ending in @sitcancer.org.
If you have any questions, please contact the SITC office at [email protected] or 414-271-2456.
Americans with Disabilities Act
Event staff will be glad to assist you with any special needs (i.e., physical, dietary, etc). Please contact SITC Staff prior to the live event at (414) 271-2456 or via email [email protected].
View the SITC Meeting Code of Conduct.
The 2020–2021 ACI series is jointly provided by Postgraduate Institute for Medicine and the Society for Immunotherapy of Cancer.
